Richard L Wasserman Selected Research

Intravenous Immunoglobulins (IVIG)

1/2021	Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies.
12/2017	RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations.
4/2017	Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency.
2/2017	Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy.
2/2017	Emerging Paradigm of Primary Immunodeficiency Disease: Individualizing Immunoglobulin Dose and Delivery to Enhance Outcomes.
1/2016	Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease.
6/2011	Efficacy, safety, and pharmacokinetics of a 10% liquid immune globulin preparation (GAMMAGARD LIQUID, 10%) administered subcutaneously in subjects with primary immunodeficiency disease.
5/2010	Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology.
6/2009	Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency.
1/2009	Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard L Wasserman Research Topics

Disease

19	Primary Immunodeficiency Diseases 01/2023 - 07/2006
12	Infections 01/2022 - 09/2010
10	Food Hypersensitivity (Food Allergy) 03/2024 - 01/2011
10	Hypersensitivity (Allergy) 03/2024 - 04/2006
6	Hereditary Angioedemas 09/2012 - 10/2009
4	Asthma (Bronchial Asthma) 05/2010 - 04/2006
2	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2016
2	Body Weight (Weight, Body) 01/2021 - 10/2009
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2017 - 04/2017
2	Edema (Dropsy) 11/2010 - 08/2010
2	Common Variable Immunodeficiency 06/2009 - 01/2009
1	Hemorrhage 10/2017
1	Poliomyelitis (Polio) 01/2016
1	Measles 01/2016
1	Lymphopenia (Lymphocytopenia) 08/2014
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 08/2014
1	Peanut Hypersensitivity (Peanut Allergy) 01/2014
1	DiGeorge Syndrome (Syndrome, DiGeorge) 02/2012
1	Vomiting 10/2009
1	Angioedema 10/2009
1	Bruton type agammaglobulinemia 01/2009
1	Fatigue 02/2008
1	Headache (Headaches) 02/2008
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2006

Drug/Important Bio-Agent (IBA)

13	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 04/2006
12	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 02/2008
10	Immunoglobulin G (IgG)IBA 10/2017 - 09/2010
5	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 07/2012 - 10/2009
4	AllergensIBA 01/2022 - 07/2014
3	Proline (L-Proline)FDA Link 02/2012 - 01/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2018 - 08/2014
2	Neutralizing AntibodiesIBA 12/2017 - 01/2016
2	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2017 - 01/2016
2	AntibodiesIBA 01/2016 - 06/2011
2	Immunoglobulin E (IgE)IBA 08/2015 - 07/2014
2	HizentraIBA 02/2014 - 09/2010
2	Albuterol (Salbutamol)FDA LinkGeneric 11/2006 - 06/2006
1	SDMIBA 01/2023
1	Therapeutic UsesIBA 04/2017
1	ElementsIBA 11/2016
1	VaccinesIBA 08/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2014
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2014
1	antineoplaston A10 (A 10)IBA 06/2011
1	apaflurane (hydrofluoroalkane)IBA 11/2006
1	Fluticasone (Cutivate)FDA LinkGeneric 06/2006
1	GlucocorticoidsIBA 06/2006
1	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2006

Therapy/Procedure

15	Therapeutics 01/2023 - 06/2006
11	Immunotherapy 03/2024 - 01/2011
1	Emergency Treatment 11/2010
1	Aftercare (After-Treatment) 10/2009
1	Subcutaneous Infusions 02/2008
1	Metered Dose Inhalers (Metered Dose Inhaler) 06/2006